Information Security/Cyber GRC Analyst
Protective Life- Full Time
- Junior (1 to 2 years)
Candidates should have a minimum of 3 years of Application Security experience, along with knowledge of access provisioning and de-provisioning, role administration, CUA implementation/support, and licensing controls. They should also possess experience with implementation of SOX and FDA audit controls, and a minimum of 3 audit cycles preferred. Experience with security administration/risk management of SAP systems, including ECC, GRC, Solution Manager, Fiori, IBP, GTS, APO, EWM, and HANA DB is preferred. A Bachelor’s degree is preferred.
As an InfoSec Quality and Compliance Analyst (SAP Cloud Security Specialist) at Illumina, you will utilize your application security skills to plan and implement security measures on various SAP systems including S/4HANA cloud, IBP, BTP, IAS, CPI, and Ariba. You will be primarily responsible for implementing access controls following security’s best practice and regulatory requirements, support audit activities, coordinate support pack upgrades, and security note implementation, maintain SAP vulnerability management program, and SAP Role/Group maintenance for SAP cloud products. Additionally, you will project lead for quarterly and weekly releases by attending project meetings, gathering requirements, providing guidance for role builds, and utilizing custom transaction codes, and conduct training to SAP Security stakeholders on best practices and risk assessment for new functionality. You will also work with SAP GRC Specialist to assess security solutions for new or existing functionality and partner with functional teams to design and implement access controls for new functionality.
Supports genomics startups through funding and resources
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.